An obligatory role for neurotensin in high-fat-diet-induced obesity

Nature

Volumn 533, Issue , 2016, Pages 411-415

  Li, Jing ^a,b   Song, Jun ^a,b   Zaytseva, Yekaterina Y ^a,b   Liu, Yajuan ^b   Rychahou, Piotr ^a,b   Jiang, Kai ^b   Starr, Marlene E ^a   Kim, Ji Tae ^a,b   Harris, Jennifer W ^a,b   Yiannikouris, Frederique B ^a   Katz, Wendy S ^a   Nilsson, Peter M ^c,d   Orho Melander, Marju ^c   Chen, Jing ^a,e   Zhu, Haining ^a,e   Fahrenholz, Timothy ^a,b   Higashi, Richard M ^a,b   Gao, Tianyan ^a,b   Morris, Andrew J ^f   Cassis, Lisa A ^a   Fan, Teresa W M ^a,b   Weiss, Heidi L ^b,e   Dobner, Paul R ^g   Melander, Olle ^c,d   Jia, Jianhang ^a,b   Evers, B Mark ^a,b   more..

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c LUND UNIVERSITY   (Sweden)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY OF KENTUCKY   (United States)

^f LEXINGTON VA MEDICAL CENTER   (United States)

^g UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LIPID; NEUROTENSIN; NEUROTENSIN RECEPTOR; NEUROTENSIN RECEPTOR 1; PRO NEUROTENSIN; PROTEIN PRECURSOR; SORTILIN; UNCLASSIFIED DRUG; PRONEUROTENSIN; VESICULAR TRANSPORT ADAPTOR PROTEIN;

AMINO ACID; CARDIOVASCULAR DISEASE; CELLS AND CELL COMPONENTS; DIABETES; ENDOCRINE SYSTEM; ENZYME ACTIVITY; FATTY ACID; FLY; FOOD CONSUMPTION; HEALTH RISK; MORTALITY; OBESITY; RODENT; TRANSLOCATION;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DROSOPHILA; ENTEROENDOCRINE CELL; ENZYME ACTIVATION; FAT BODY; FATTY LIVER; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INSULIN RESISTANCE; INTESTINE ABSORPTION; INTESTINE CELL; LIPID ABSORPTION; LIPID DIET; LIPID STORAGE; LIVER CELL; LONGITUDINAL STUDY; MALE; MIDGUT; MOUSE; NONHUMAN; OBESITY; OENOCYTE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; ADVERSE EFFECTS; ANIMAL; BLOOD; CELL LINE; CHEMICALLY INDUCED; CYTOLOGY; DEFICIENCY; DISEASE MODEL; DROSOPHILA MELANOGASTER; ENZYMOLOGY; GENETICS; INTESTINE; LIPID METABOLISM; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

MUS; RATTUS;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELL LINE; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DROSOPHILA MELANOGASTER; ENTEROENDOCRINE CELLS; ENZYME ACTIVATION; FAT BODY; FATTY ACIDS; FATTY LIVER; FEMALE; HUMANS; INSULIN RESISTANCE; INTESTINES; LIPID METABOLISM; MALE; MICE; MIDDLE AGED; NEUROTENSIN; OBESITY; PROTEIN PRECURSORS;

EID: 84969924791     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature17662     Document Type: Article

References (64)

1. Ogden, C. L., Yanovski, S. Z., Carroll, M. D. & Flegal, K. M. The epidemiology of obesity. Gastroenterology 132, 2087-2102 (2007).
2. Kopelman, P. G. Obesity as a medical problem. Nature 404, 635-643 (2000).
3. Guh, D. P. et al. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 9, 88 (2009).
4. Polak, J. M. et al. Specific localisation of neurotensin to the N cell in human intestine by radioimmunoassay and immunocytochemistry. Nature 270, 183-184 (1977).
5. Ferris, C. F., Hammer, R. A. & Leeman, S. E. Elevation of plasma neurotensin during lipid perfusion of rat small intestine. Peptides 2 (suppl. 2), 263-266 (1981).
6. Armstrong, M. J., Parker, M. C., Ferris, C. F. & Leeman, S. E. Neurotensin stimulates [3H]oleic acid translocation across rat small intestine. Am. J. Physiol. 251, G823-G829 (1986).
7. Evers, B. M. Neurotensin and growth of normal and neoplastic tissues. Peptides 27, 2424-2433 (2006).
8. Vincent, J. P., Mazella, J. & Kitabgi, P. Neurotensin and neurotensin receptors. Trends Pharmacol. Sci. 20, 302-309 (1999).
9. Melander, O. et al. Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortality. J. Am. Med. Assoc. 308, 1469-1475 (2012).
10. Dobner, P. R., Fadel, J., Deitemeyer, N., Carraway, R. E. & Deutch, A. Y. Neurotensin-deficient mice show altered responses to antipsychotic drugs. Proc. Natl Acad. Sci. USA 98, 8048-8053 (2001).
11. Piliponsky, A. M. et al. Neurotensin increases mortality and mast cells reduce neurotensin levels in a mouse model of sepsis. Nature Med. 14, 392-398 (2008).
12. Sahu, A., Carraway, R. E. & Wang, Y. P. Evidence that neurotensin mediates the central effect of leptin on food intake in rat. Brain Res. 888, 343-347 (2001).
13. Boules, M. et al. A novel neurotensin peptide analog given extracranially decreases food intake and weight in rodents. Brain Res. 865, 35-44 (2000).
14. Cooke, J. H. et al. Peripheral and central administration of xenin and neurotensin suppress food intake in rodents. Obesity (Silver Spring) 17, 1135-1143 (2009).
15. Martin, S., Navarro, V., Vincent, J. P. & Mazella, J. Neurotensin receptor-1 and -3 complex modulates the cellular signaling of neurotensin in the HT29 cell line. Gastroenterology 123, 1135-1143 (2002).
16. Rabinowich, L. et al. Sortilin deficiency improves the metabolic phenotype and reduces hepatic steatosis of mice subjected to diet-induced obesity. J. Hepatol. 62, 175-181 (2015).
17. Lim, C. T., Kola, B. & Korbonits, M. AMPK as a mediator of hormonal signalling. J. Mol. Endocrinol. 44, 87-97 (2010).
18. Xue, B. & Kahn, B. B. AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues. J. Physiol. 574, 73-83 (2006).
19. Hardie, D. G. AMPK: positive and negative regulation, and its role in wholebody energy homeostasis. Curr. Opin. Cell Biol. 33, 1-7 (2015).
20. Racioppi, L. & Means, A. R. Calcium/calmodulin-dependent protein kinase kinase 2: roles in signaling and pathophysiology. J. Biol. Chem. 287, 31658-31665 (2012).
21. Shackelford, D. B. & Shaw, R. J. The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nature Rev. Cancer 9, 563-575 (2009).
22. Park, J. H. & Kwon, J. Y. Heterogeneous expression of Drosophila gustatory receptors in enteroendocrine cells. PLoS ONE 6, e29022 (2011).
23. Micchelli, C. A. & Perrimon, N. Evidence that stem cells reside in the adult Drosophila midgut epithelium. Nature 439, 475-479 (2006).
24. Ohlstein, B. & Spradling, A. The adult Drosophila posterior midgut is maintained by pluripotent stem cells. Nature 439, 470-474 (2006).
25. Birse, R. T. et al. High-fat-diet-induced obesity and heart dysfunction are regulated by the TOR pathway in Drosophila. Cell Metab. 12, 533-544 (2010).
26. Hewes, R. S. & Taghert, P. H. Neuropeptides and neuropeptide receptors in the Drosophila melanogaster genome. Genome Res. 11, 1126-1142 (2001).
27. Park, Y., Kim, Y. J. & Adams, M. E. Identification of G protein-coupled receptors for Drosophila PRXamide peptides, CCAP, corazonin, and AKH supports a theory of ligand-receptor coevolution. Proc. Natl Acad. Sci. USA 99, 11423-11428 (2002).
28. Song, W., Veenstra, J. A. & Perrimon, N. Control of lipid metabolism by tachykinin in Drosophila. Cell Reports 9, 40-47 (2014).
29. Amcheslavsky, A. et al. Enteroendocrine cells support intestinal stem-cellmediated homeostasis in Drosophila. Cell Reports 9, 32-39 (2014).
30. Anderson, K. A. et al. Hypothalamic CaMKK2 contributes to the regulation of energy balance. Cell Metab. 7, 377-388 (2008).
31. Fadel, J., Dobner, P. R. & Deutch, A. Y. Amphetamine-elicited striatal Fos expression is attenuated in neurotensin null mutant mice. Neurosci. Lett. 402, 97-101 (2006).
32. Steinberg, R. et al. SR 48692, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behaviour and changes in dopaminergic transmission. Neuroscience 59, 921-929 (1994).
33. Fadel, J., Dobner, P. R. & Deutch, A. Y. The neurotensin antagonist SR 48692 attenuates haloperidol-induced striatal Fos expression in the rat. Neurosci. Lett. 303, 17-20 (2001).
34. Owens, R. B., Smith, H. S., Nelson-Rees, W. A. & Springer, E. L. Epithelial cell cultures from normal and cancerous human tissues. J. Natl. Cancer Inst. 56, 843-849 (1976).
35. Song, J., Li, J., Lulla, A., Evers, B. M. & Chung, D. H. Protein kinase D protects against oxidative stress-induced intestinal epithelial cell injury via Rho/ROK/PKC-δ pathway activation. Am. J. Physiol. Cell Physiol. 290, C1469-C1476 (2006).
36. Li, J. et al. mTORC1 inhibition increases neurotensin secretion and gene expression through activation of the MEK/ERK/c-Jun pathway in the human endocrine cell line BON. Am. J. Physiol. Cell Physiol. 301, C213-C226 (2011).
37. Li, J. et al. Cyclic adenosine 5′-monophosphate-stimulated neurotensin secretion is mediated through Rap1 downstream of both Epac and protein kinase A signaling pathways. Mol. Endocrinol. 21, 159-171 (2007).
38. Yiannikouris, F. et al. Adipocyte-specific deficiency of angiotensinogen decreases plasma angiotensinogen concentration and systolic blood pressure in mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 302, R244-R251 (2012).
39. Salous, A. K. et al. Mechanism of rapid elimination of lysophosphatidic acid and related lipids from the circulation of mice. J. Lipid Res. 54, 2775-2784 (2013).
40. Onono, F. et al. Efficient use of exogenous isoprenols for protein isoprenylation by MDA-MB-231 cells is regulated independently of the mevalonate pathway. J. Biol. Chem. 288, 27444-27455 (2013).
41. Moolenbeek, C. & Ruitenberg, E. J. The "Swiss roll": a simple technique for histological studies of the rodent intestine. Lab. Anim. 15, 57-59 (1981).
42. Fan, T. W., Lane, A. N., Higashi, R. M. & Yan, J. Stable isotope resolved metabolomics of lung cancer in a SCID mouse model. Metabolomics 7, 257-269 (2011).
43. Lane, A. N., Fan, T. W., Xie, Z., Moseley, H. N. & Higashi, R. M. Isotopomer analysis of lipid biosynthesis by high resolution mass spectrometry and NMR. Anal. Chim. Acta 651, 201-208 (2009).
44. Palanker, L., Tennessen, J. M., Lam, G. & Thummel, C. S. Drosophila HNF4 regulates lipid mobilization and β-oxidation. Cell Metab. 9, 228-239 (2009).
45. Jia, H., Liu, Y., Yan, W. & Jia, J. PP4 and PP2A regulate Hedgehog signaling by controlling Smo and Ci phosphorylation. Development 136, 307-316 (2009).
46. Hipkiss, A. R. On why decreasing protein synthesis can increase lifespan. Mech. Ageing Dev. 128, 412-414 (2007).
47. Stenesen, D. et al. Adenosine nucleotide biosynthesis and AMPK regulate adult life span and mediate the longevity benefit of caloric restriction in flies. Cell Metab. 17, 101-112 (2013).
48. Alfa, R. W. et al. Suppression of insulin production and secretion by a decretin hormone. Cell Metab. 21, 323-333 (2015).
49. Park, J. H. & Kwon, J. Y. A systematic analysis of Drosophila gustatory receptor gene expression in abdominal neurons which project to the central nervous system. Mol. Cells 32, 375-381 (2011).
50. Scopelliti, A. et al. Local control of intestinal stem cell homeostasis by enteroendocrine cells in the adult Drosophila midgut. Curr. Biol. 24, 1199-1211 (2014).
51. Wang, P. & Hou, S. X. Regulation of intestinal stem cells in mammals and Drosophila. J. Cell. Physiol. 222, 33-37 (2010).
52. Jiang, H. & Edgar, B. A. EGFR signaling regulates the proliferation of Drosophila adult midgut progenitors. Development 136, 483-493 (2009).
53. Gutzwiller, L. M. et al. Proneural and abdominal Hox inputs synergize to promote sensory organ formation in the Drosophila abdomen. Dev. Biol. 348, 231-243 (2010).
54. Jiang, K. et al. Hedgehog-regulated atypical PKC promotes phosphorylation and activation of Smoothened and Cubitus interruptus in Drosophila. Proc. Natl Acad. Sci. USA 111, E4842-E4850 (2014).
55. Liu, Y., Cao, X., Jiang, J. & Jia, J. Fused-Costal2 protein complex regulates Hedgehog-induced Smo phosphorylation and cell-surface accumulation. Genes Dev. 21, 1949-1963 (2007).
56. Yang, L., Gal, J., Chen, J. & Zhu, H. Self-assembled FUS binds active chromatin and regulates gene transcription. Proc. Natl Acad. Sci. USA 111, 17809-17814 (2014).
57. Reiher, W. et al. Peptidomics and peptide hormone processing in the Drosophila midgut. J. Proteome Res. 10, 1881-1892 (2011).
58. Bergland, G. Minisymposium: The Malmö Diet and Cancer Study. Design, biological bank and biomarker programme. J. Intern. Med. 233, 39-79 (1993).
59. Persson, M., Berglund, G., Nelson, J. J. & Hedblad, B. Lp-PLA2 activity and mass are associated with increased incidence of ischemic stroke: a populationbased cohort study from Malmö, Sweden. Atherosclerosis 200, 191-198 (2008).
60. Matthews, D. R. et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419 (1985).
61. Alberti, K. G., Zimmet, P. & Shaw, J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet. Med. 23, 469-480 (2006).
62. Ernst, A., Hellmich, S. & Bergmann, A. Proneurotensin 1-117, a stable neurotensin precursor fragment identified in human circulation. Peptides 27, 1787-1793 (2006).
63. Enhörning, S. et al. Plasma copeptin and the risk of diabetes mellitus. Circulation 121, 2102-2108 (2010).
64. Li, J. et al. PI3K p110α/Akt signaling negatively regulates secretion of the intestinal peptide neurotensin through interference of granule transport. Mol. Endocrinol. 26, 1380-1393 (2012).